Dealmaking

EY's Arda Ural: Big pharma is driving a rebound in biopharma and medtech M&A

The most sought-after targets are small- to mid-sized companies focused on high-growth therapeutic areas, such as oncology, cardiometabolic, immunology, central nervous system and rare diseases.

Synova sees 6.5x return with Vistair sale

Insight Partners and Liberty Hall Capital Partners have acquired Vistair, merging the company with Comply365.

Waterland takes majority stake in Cumbria Waste Group

CWG comprises Cumbria Waste Management, Cumbria Waste Recycling and Lakeland Waste Management.

ECI promotes two to partner

In addition to the new partners, ECI has also promoted Jin Ni Ooi to the role of investment manager.

UK take-privates tipped for growth by Peel Hunt

Bain Capital still in talks with SoftwareOne.

Mutares parts with Valti

Valti is a European manufacturer of seamless high-precision steel tubes serving the bearing manufacturer industry.

Stirling Square, TA, Macquarie in SKr10.1bn bid for Byggfakta

Byggfakta is a software and information company within the construction industry.

Stanley Capital promotes Rodolphe Louvet to principal

Louvet started as an associate with Stanley Capital in 2022.

Thoma Bravo closes BlueMatrix deal; DPI identifies investment opportunities in Africa

Thoma Bravo backs investment research publisher BlueMatrix.

DPI’s Marc Stoneham: Africa's growing urbanization, population growth and digitization make it compelling

'As a pan-African investor, DPI looks at the whole continent and our portfolio is spread across more than 40 countries,' said Stoneham.